The existence of several contradictory results about the role of CB2 signaling on energy homeostasis and obesity-associated inflammation can be associated with the use of CB2 receptor-deleted animals, as well as to the existence of several differences between the experimental protocols performed by the different researchers. The gene discussed is CNR2; the disease is obesity due to melanocortin 4 receptor deficiency.